Cargando…
Effects of glucagon‐like peptide‐1 receptor agonists on kidney function and safety in type 2 diabetes patients
Glucagon‐like peptide‐1 receptor agonists have been recommended in diabetic kidney disease patients.[Image: see text]
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169368/ https://www.ncbi.nlm.nih.gov/pubmed/33759351 http://dx.doi.org/10.1111/jdi.13552 |